Login / Signup

The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17.

Adrian H HealdMark LivingstonZuzanna BienGabriela Y C MorenoIan LaingMike Stedman
Published in: International journal of clinical practice (2018)
Our work demonstrates the significant cost of medication to modulate tissue glucose levels in type 2 diabetes and the dominance of some non-generic preparations in terms of number of prescriptions and overall spend. There are some older sulphonylureas in use, which should not generally be prescribed. Regular audit of patient treatment at a general practice level will ensure appropriate targeted use of licensed medications and of their cost effectiveness.
Keyphrases